Literature DB >> 4953172

Electron microscopic study of trabecular meshwork in clinical and experimental glaucoma with anterior chamber hemorrhage.

T Yamashita, D A Rosen.   

Abstract

Entities:  

Mesh:

Year:  1965        PMID: 4953172

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  8 in total

1.  Anterior chamber angle recession in uveal melanomas.

Authors:  F Vrabec; P Kuchynka
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-07-17

2.  Further observations on the process of haemophagocytosis in the human outflow system.

Authors:  I Grierson; W R Lee
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1978-11-08

3.  The electron microscopy of Schlemm's canal and adjacent structures in patients with glaucoma.

Authors:  A I Fink; M D Felix; R C Fletcher
Journal:  Trans Am Ophthalmol Soc       Date:  1972

4.  Erythrocyte phagocytosis in the human trabecular meshwork.

Authors:  I Grierson; W R Lee
Journal:  Br J Ophthalmol       Date:  1973-06       Impact factor: 4.638

5.  [Electron microscopic studies of the hyalinization of the corneo-scleral trabeculum in secondary glaucoma].

Authors:  J W Rohen; W Straub
Journal:  Albrecht Von Graefes Arch Klin Exp Ophthalmol       Date:  1967

6.  Clearance of debris from the iris through the drainage angle of the rabbit's eye.

Authors:  I Grierson; I A Chisholm
Journal:  Br J Ophthalmol       Date:  1978-10       Impact factor: 4.638

7.  Up-regulated expression of extracellular matrix remodeling genes in phagocytically challenged trabecular meshwork cells.

Authors:  Kristine M Porter; David L Epstein; Paloma B Liton
Journal:  PLoS One       Date:  2012-04-18       Impact factor: 3.240

8.  Cathepsin B is up-regulated and mediates extracellular matrix degradation in trabecular meshwork cells following phagocytic challenge.

Authors:  Kristine Porter; Yizhi Lin; Paloma B Liton
Journal:  PLoS One       Date:  2013-07-03       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.